Your browser doesn't support javascript.
loading
ß3-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes.
Schobesberger, Sophie; Wright, Peter T; Poulet, Claire; Sanchez Alonso Mardones, Jose L; Mansfield, Catherine; Friebe, Andreas; Harding, Sian E; Balligand, Jean-Luc; Nikolaev, Viacheslav O; Gorelik, Julia.
Affiliation
  • Schobesberger S; Myocardial Function, National Heart and Lung Institute, Imperial College London, ICTEM, Hammersmith Hospital, London, United Kingdom.
  • Wright PT; Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, German Center for Cardiovascular Research (DZHK) partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
  • Poulet C; Myocardial Function, National Heart and Lung Institute, Imperial College London, ICTEM, Hammersmith Hospital, London, United Kingdom.
  • Sanchez Alonso Mardones JL; Myocardial Function, National Heart and Lung Institute, Imperial College London, ICTEM, Hammersmith Hospital, London, United Kingdom.
  • Mansfield C; Myocardial Function, National Heart and Lung Institute, Imperial College London, ICTEM, Hammersmith Hospital, London, United Kingdom.
  • Friebe A; Myocardial Function, National Heart and Lung Institute, Imperial College London, ICTEM, Hammersmith Hospital, London, United Kingdom.
  • Harding SE; Physiologisches Institut, University of Würzburg, Würzburg, Germany.
  • Balligand JL; Myocardial Function, National Heart and Lung Institute, Imperial College London, ICTEM, Hammersmith Hospital, London, United Kingdom.
  • Nikolaev VO; Pole of Pharmacology and Therapeutics (FATH), Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain (UCLouvain), Brussels, Belgium.
  • Gorelik J; Institute of Experimental Cardiovascular Research, University Medical Center Hamburg-Eppendorf, German Center for Cardiovascular Research (DZHK) partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
Elife ; 92020 03 31.
Article in En | MEDLINE | ID: mdl-32228862
ABSTRACT
Cardiomyocyte ß3-adrenoceptors (ß3-ARs) coupled to soluble guanylyl cyclase (sGC)-dependent production of the second messenger 3',5'-cyclic guanosine monophosphate (cGMP) have been shown to protect from heart failure. However, the exact localization of these receptors to fine membrane structures and subcellular compartmentation of ß3-AR/cGMP signals underpinning this protection in health and disease remain elusive. Here, we used a Förster Resonance Energy Transfer (FRET)-based cGMP biosensor combined with scanning ion conductance microscopy (SICM) to show that functional ß3-ARs are mostly confined to the T-tubules of healthy rat cardiomyocytes. Heart failure, induced via myocardial infarction, causes a decrease of the cGMP levels generated by these receptors and a change of subcellular cGMP compartmentation. Furthermore, attenuated cGMP signals led to impaired phosphodiesterase two dependent negative cGMP-to-cAMP cross-talk. In conclusion, topographic and functional reorganization of the ß3-AR/cGMP signalosome happens in heart failure and should be considered when designing new therapies acting via this receptor.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Cyclic GMP / Receptors, Adrenergic, beta-3 / Myocytes, Cardiac / Cyclic Nucleotide Phosphodiesterases, Type 2 Limits: Animals Language: En Journal: Elife Year: 2020 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Cyclic GMP / Receptors, Adrenergic, beta-3 / Myocytes, Cardiac / Cyclic Nucleotide Phosphodiesterases, Type 2 Limits: Animals Language: En Journal: Elife Year: 2020 Document type: Article Affiliation country: United kingdom